Daré Bioscience (DARE) Stock Statistics & Valuation Metrics

Daré Bioscience has a market cap or net worth of $26.29M. The enterprise value is $22.31M.

Daré Bioscience has 8,850,386 shares outstanding. The number of shares has decreased by -2.65% in one year.

Daré Bioscience’s return on equity (ROE) is 5.98 and return on invested capital (ROIC) is -2427.37%.

The current PE Ratio of Daré Bioscience is -0.95. Daré Bioscience’s PEG ratio is 0.17.

In the last 12 months, Daré Bioscience had revenue of 2.81M and earned -30.16M in profits. Earnings per share was -4.15.

In the last 12 months, operating cash flow was -20.92M and capital expenditures -332.30K, giving a free cash flow of -21.26M billion.

Daré Bioscience pays an annual dividend of ―, resulting in a dividend yield of ―

Daré Bioscience upcoming earnings date is May 8, 2025, TBA Not Confirmed.

Daré Bioscience as a current ratio of 0.86, with Debt / Equity ratio of -94.55%

In the past 12 months, Daré Bioscience has paid 0.00 in taxes.

Daré Bioscience EV to EBITDA ratio is -0.64, with an EV/FCF ratio of -0.50.

Daré Bioscience has $11.23M in cash and marketable securities with $22.82M in debt, giving a net cash position of -$9.83M billion.

Gross margin is 97.57%, with operating margin of -1098.33%, and net profit margin of -1074.17%.

The average price target for Daré Bioscience is $12.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy